Promotional Challenges and Considerations for Rare Disease Treatments According to FDA statistics, over 7,000 rare diseases affect more than 30 million people in the US. The collective number of diseases is large, but the number of patients affected by each disease is small, resulting in smaller clinical datasets. This interactive session will engage attendees [...]
Topic Suggestions Is there a specific topic you would like to see addressed in a future FDLI event? If so, please share your suggestions on our online portal.
Why Attend Agenda Location & CLE Agenda Subject to Change All Times Listed in Eastern Time Wednesday, December 6 FDLI Welcome, Opening Remarks, and Keynote Address Christine M. Simmon, President & CEO, Food and Drug Law Institute Beth P. Weinman, Counsel, Ropes & Gray [...]
Topic Suggestions Is there a specific topic you would like to see addressed in a future FDLI event? If so, please share your suggestions on our online portal.
Topic Suggestions Is there a specific topic you would like to see addressed in a future FDLI event? If so, please share your suggestions on our online portal.
Fall 2023 Full Issue If you are experiencing difficulties accessing the magazine, please click here.
Director, Educational Programs The Food and Drug Law Institute (FDLI) is a nonprofit membership organization that offers education, training, publications, and professional engagement opportunities in the field of food and drug law. As a neutral convener, FDLI provides a venue for stakeholders to inform innovative public policy, law, and regulation. FDLI’s scope covers all [...]
Why Attend Agenda Location & CLE Agenda Subject to Change All Times Listed in Eastern Time Thursday, November 2 Christine Simmon, President & CEO, FDLI Mark Gardner, Directing Attorney, Gardner Law, PLLC, and 2023 FDLI A&P Conference Co-Chair Arun G. Rao, Deputy [...]
Why Attend Agenda Location & CLE Agenda Subject to Change All Times Listed in Eastern Time Thursday, October 26 Christine M. Simmon, President & CEO, FDLI Brian King, Director, Center for Tobacco Products (CTP), US Food and Drug Administration (FDA) Tony Abboud, Executive Director, [...]
Why Attend Agenda Location & CLE All Times Listed in Eastern Time Wednesday, September 27 Christine M. Simmon, President & CEO, FDLI Stefanie Jill Fogel, Partner, DLA Piper LLP and Chair, 2023 Food Advertising, Labeling, and Litigation Conference Planning Committee Douglas W. Stearn, Deputy [...]
Virtual Learning
Programs
Resources
Get Involved
Career
About
Fill out the form below to receive emails highlighting our upcoming programs, early registration savings, and engagement opportunities for the food and drug law community.
